General Description
17α-Methyl-3-ethoxypregna-3,5-dien-20-one is a steroid derivative featuring a methyl substituent at the C-17α position, an ethoxy group at C-3, and a diene system (pregna-3,5-diene) with a ketone at C-20. This is a highly modified steroidal intermediate with multiple points of structural elaboration relative to the parent steroid nucleus. The 17α-methyl and 3-ethoxy modifications confer enhanced oral bioavailability and altered pharmacokinetics compared to natural steroids.
Mechanism of Action
17α-Methyl-3-ethoxypregna-3,5-dien-20-one functions as a steroid intermediate in the synthesis of modified anabolic steroids, oral contraceptives, and anti-inflammatory steroids. The 17α-methyl group blocks 17-hydroxylation, extending the steroid half-life by preventing its degradation via the CYP17 pathway. The 3-ethoxy group (an enol ether) is hydrolyzed in vivo to the 3-ketone, the active form. The 3,5-diene (conjugated diene) system contributes to UV absorption and photochemical reactivity.
Application
17α-Methyl-3-ethoxypregna-3,5-dien-20-one is used as an intermediate in the synthesis of anabolic steroids (nandrolone and oxandrolone derivatives), oral progestins, and corticosteroids. The steroid scaffold is foundational to many hormonal therapeutics targeting androgen, estrogen, progestin, glucocorticoid, and mineralocorticoid receptors. It is also used in the synthesis of bile acid derivatives and steroidal sensors.